Contents
Editor’s Letter
What to look forward to in GaBI Journal, 2021, Issue 2
Original Research
Summative usability evaluation of the YLB113 etanercept biosimilar autoinjector via simulation
Biosimilars in Saudi Arabia: a single-centre, open-label case series examining infliximab switching
Variation in the prices of oncology medicines across Europe and the implications for the future
Review Article
An overview of the current status of follow-on biologicals in Iran